SCHEMBL6396170

SCHEMBL6396170

Nc1ccc(-c2cc(N(c3ccccc3)c3ccccc3)ccc2-c2ccc(N)cc2-c2ccc(N(c3ccccc3)c3ccccc3)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
CYP3A4 P08684 3/20 0.60
TDP1 Q9NUW8 3/20 0.60
MAPT P10636 3/20 0.60
KDM4E B2RXH2 2/20 0.60
L3MBTL1 Q9Y468 2/20 0.60
CYP1A2 P05177 1/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
TAAR1 Q96RJ0 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
NPC1 O15118 3/20 0.41
HPGD P15428 3/20 0.41
NCOA1 Q15788 3/20 0.41
PTPRC P08575 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30128689 0.93 ALDH1A1 (0.64) ALDH1A1CYP3A4TDP1MAPTKDM4E
SCHEMBL3038725 0.93 ALDH1A1 (0.64) ALDH1A1CYP3A4TDP1MAPTKDM4E
SCHEMBL28036730 0.93 ALDH1A1 (0.64) ALDH1A1CYP3A4TDP1MAPTKDM4E
SCHEMBL15449462 0.92 ALDH1A1 (0.62) ALDH1A1CYP3A4TDP1MAPTKDM4E
SCHEMBL29693287 0.92 ALDH1A1 (0.62) ALDH1A1CYP3A4TDP1MAPTKDM4E
SCHEMBL973065 0.91 ALDH1A1 (0.61) ALDH1A1CYP3A4TDP1MAPTKDM4E
SCHEMBL28836453 0.90 ALDH1A1 (0.60) ALDH1A1CYP3A4TDP1MAPTKDM4E
SCHEMBL2574125 0.90 ALDH1A1 (0.59) ALDH1A1CYP3A4TDP1MAPTKDM4E
SCHEMBL23780954 0.88 ALDH1A1 (0.46) ALDH1A1CYP3A4TDP1MAPTKDM4E
SCHEMBL8666169 0.88 ALDH1A1 (0.53) ALDH1A1CYP3A4TDP1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050236976-A1 Organic electroluminescent device RITDISPLAY CORPORATION (TW) 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050236976-A1 Organic electroluminescent device ARL1, OR10J3, MCOLN1 ALDH1A1 593/4885CYP3A4 2783/4885TDP1 4482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.